Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-22

FDA Approved: ADCIRCA — Original Application (United Therapeutics Corporation)

View source ↗

Summary

FDA approved Adcirca (tadalafil) under the original application from United Therapeutics for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adcirca (tadalafil)

Snippet

ORIG AP for ADCIRCA (TADALAFIL)